Medikaloka Hermina PT (HEAL)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 505.00 |
|---|---|
| 52-week range | 470.00 – 1,511.39 |
| Return, 1 month / 3 months | −23.5% / −39.2% |
| Return, 1 year / 3 years | −66.0% / −64.0% |
| Trend | Below its 200-day average |
| RSI (14) | 18 |
| Volatility (1 year) | 40.1% |
| Worst drawdown (1 year) | -66.3% |
| Average daily value traded | 10,896.92M IDR |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Medikaloka Hermina, known as Hermina Hospitals, runs a network of private hospitals across Indonesia. The company offers general and specialist medical care, with particular strength in maternity, pediatric and women's health services, alongside outpatient clinics and emergency care. Its patients are mainly Indonesian families and individuals seeking private healthcare in cities and regional centres throughout the archipelago. The company is headquartered in Jakarta and operates its hospitals under the Hermina name.
Medikaloka Hermina PT trades under the code HEAL on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Medikaloka Hermina PT (HEAL) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 505.00 on 19 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 672 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 66.0% and over the last three months it fell 39.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -48.8% | ||
| From 52-week high | -66.3% | ||
| Momentum | 7 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -39.2% | ||
| 6-month return | -57.2% | ||
| 12-month return, skipping the last month | -55.6% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -66.3% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 10,896.92M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −16.5% |
|---|---|
| 1 month | −23.5% |
| 3 months | −39.2% |
| 6 months | −57.2% |
| 1 year | −66.0% |
| 3 years | −64.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 649.80 / 985.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 26.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | IDR 13.5000 |
| 5 May 2025 | IDR 10.5000 |
| 22 May 2024 | IDR 8.5000 |
| 12 Jun 2023 | IDR 7.0000 |
| 7 Jun 2022 | IDR 6.0000 |
| 11 Jun 2021 | IDR 25.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.